Cipla receives US FDA approval for generic version of Abraxane
Cipla secures final USFDA approval for Protein-bound Paclitaxel 100 mg/vial; launch planned in H1 FY26 in the US market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cipla
Cipla, Formosa sign multi-regional licensing deal for Clobetasol Suspension
This partnership aims to enhance ophthalmic care by providing treatment for post- operative inflammation and pain in patients…
AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma…
Ramandeep Singh, Vice President, Life Sciences and Healthcare, India, Clarivate, discusses the latest innovative R&D,…
Being complacent in pharma quality: Five minutes to midnight
Dr Sumedha Nadkar, Pharma Consultant and Visiting Faculty, shares a hard-hitting article which highlights that complacency in…
The 6th X-CIPLOG reunion event 2025 was held in Mumbai
X-CIPLOG Reunion 2025 and Excellence Awards reflect industry recognition resonating with the government’s padma bhushan honour to…
Cipla launches CipAir App for asthma screening in India
CipAir provides AI-driven asthma screening, enabling timely diagnosis and better respiratory care
Cipla’s manufacturing facility in Goa gets VAI classification
The US FDA conducted a cGMP inspection between June 10-21, 2024
MK Hamied, Vice Chairman and Non-Executive Director, Cipla steps down
Cipla announces appointment of Kamil Hamied as Non-Executive Director
Cannes Lions 2024 showcase highlights key trends shaping future pharma marketing
The showcase hosted by The Work from LIONS, in collaboration with Medulla Communications, analysed the most impactful campaigns…
Orchid Pharma, Cipla to launch antibiotic Cefepime-Enmetazobactam in India
This alliance aims to rapidly deploy Orchid’s novel anti-infective invented in India to address the rising threat of antimicrobial…